Proteins and Peptides

28 Feb 2007 Human Genome Sciences Initiates Phase 3 Clinical Trial Of Albuferon(R) With Ribavirin In Treatment-Naïve Patients With Chronic Hepatitis C Genotypes 2 And 3
27 Feb 2007 Bristol-Myers Squibb Company and Adnexus Therapeutics Announce Collaboration to Develop and Commercialize Innovative Oncology Compounds
27 Feb 2007 Phase 3 stroke trial shows that NovoSeven® reduces bleeding in the brain, but does not improve long-term clinical outcomes
27 Feb 2007 Lilly Plans New Clinical Trial of Xigris
27 Feb 2007 Ipsen Grants Galderma Exclusive Rights to Develop, Promote and Distribute Its Botulinum Toxin Type A Product for Aesthetic Indications in Europe and Certain Other Territories
26 Feb 2007 TOP Classes of Biologics with 2006 Sales of US$ 63.8 bln
24 Feb 2007 Recruitment temporarily suspended into C.E.R.A. Phase II oncology trial
22 Feb 2007 Breakthrough oral delivery for arthritis sufferers
22 Feb 2007 BioMimetic Therapeutics Receives Orphan Drug Designation for rhPDGF-BB Treatment of Osteonecrosis of the Jaw
22 Feb 2007 Allon files IND for approval of Schizophrenia Phase II clinical trials
21 Feb 2007 Auxilium Announces Results from Phase III Trial that Show AA4500 Successful in Treating Dupuytren's Contracture
21 Feb 2007 Bentley Announces Approval and Expansion of Its Nasulin Phase II Studies in India
21 Feb 2007 Dyax and Genzyme Announce Agreement to Terminate Joint Venture for the Commercialization of DX-88 in HAE
17 Feb 2007 OrthoLogic Announces Results of Post Hoc Subgroup Analysis of Data From Phase 3 Clinical Trial of Chrysalin (TP508) in Fracture Repair
16 Feb 2007 Stem Cell Sciences and Celogos Sign a Licensing Deal on Autogenous Myoblast Transplantation For Urinary Incontinence Therapy
16 Feb 2007 FDA Accepts ZymoGenetics' Recombinant Human Thrombin Application for Review
15 Feb 2007 Halozyme and Baxter Expand Global HYLENEX Collaboration
15 Feb 2007 Halozyme Therapeutics and Baxter Present Promising Results for the Use of HYLENEX from the Infuse-Morphine Study
14 Feb 2007 Sangart, Inc. Initiates Phase III Clinical Trials
13 Feb 2007 Ambrx Initiates Phase I/II Clinical Trial of Novel Human Growth Hormone Product Candidate
13 Feb 2007 QSV Biologics, Ltd., and Critical Biologics Corp., Sign Contract for cGMP Manufacture of Gelsolin for Critical Care Applications
09 Feb 2007 Zelos Therapeutics' Ostabolin-CTM Increases Bone Mineral Density in Phase 2 Osteoporosis Trial
09 Feb 2007 EU-Approval for Continuous Infusion of KOGENATE(R) Bayer
09 Feb 2007 LAB International Completes Patient Enrollment in Its Growth Hormone Releasing Hormone (GHRH) Product Phase IIA Trial
09 Feb 2007 Amarillo Biosciences Announces Open Enrollment in Its Phase 2 Study of Orally Administered Interferon Alpha in the Treatment of Oral Warts in HIV-Positive Patients

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up